ABSTRACT:
The resurgence of monkeypox, a once-rare zoonotic disease, has sparked global concern as it spreads beyond its traditional confines in Central and West Africa. With a history of sporadic outbreaks, monkeypox was long considered a localized threat, primarily transmitted from animals to humans in remote areas. However, the recent proliferation of cases in non-endemic regions has highlighted the virus's potential to cause widespread public health crises. This review delves into the intricate details of the monkeypox virus, examining its structure, genetic makeup, and the differences between its two main clades: the Central African and West African variants. The article further explores the clinical manifestations of monkeypox, emphasizing the importance of early diagnosis and the challenges of distinguishing it from other pox-like illnesses. As the world grapples with the ongoing threat of monkeypox, understanding its modes of transmission, symptoms, and available treatments is crucial for effective management. The article also addresses the broader implications of the outbreak, including its impact on global health systems, economies, and communities. Through a comprehensive analysis, this review aims to provide a detailed understanding of monkeypox and the strategies needed to combat its spread, highlighting the lessons learned from recent outbreaks and the importance of preparedness in preventing future pandemics.
Cite this article:
Harsh M. Kashid. The Resurgence of Monkeypox: A Review of its Outbreak, Structure, Symptoms, and Global Impact. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(3):287-2. doi: 10.52711/2231-5659.2025.00042
Cite(Electronic):
Harsh M. Kashid. The Resurgence of Monkeypox: A Review of its Outbreak, Structure, Symptoms, and Global Impact. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(3):287-2. doi: 10.52711/2231-5659.2025.00042 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2025-15-3-9
REFERENCES:
1. Monkeypox Fact Sheet. World Health Organization (WHO). [Online] August 26, 2024. [Cited: September 02, 2024.] https://www.who.int/news-room/fact-sheets/detail/monkeypox.
2. IK, McCollum AM, Damon. Human Monkeypox. S.L. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America, 2014; 58: 260-267.
3. Genomic Variability of monkeypox virus among humans, Democratic Republic of the Congo. Kugelman, J. R., Johnston, S. C., Mulembakani, P. M., Kisalu, N., Lee, M. S., Koroleva, G., McCarthy, S. E., Gestole, M. C., Wolfe, N. D., Fair, J. N., Schneider, B. S., Wright, L. L., Huggins, J., Whitehouse, C. A., Wemakoy, E. O., Muyembe-Tamfum, J. J. Emerging infectious diseases. 2014; 20: 232–239.
4. A tale of two clades: monkeypox viruses. Likos, A. M., Sammons, S. A., Olson, V. A., Frace, A. M., Li, Y., Olsen-Rasmussen, M., Davidson, W., Galloway, R., Khristova, M. L., Reynolds, M. G., Zhao, H., Carroll, D. S., Curns, A., Formenty, P., Esposito, J. J., Regnery, R. L., Damon, I. K. 10, , The Journal of General Virology. 2005; 86: 2661–2672.
6. Clinical manifestations of human monkeypox influenced by route of infection. Reynolds, M. G., Yorita, K. L., Kuehnert, M. J., Davidson, W. B., Huhn, G. D., Holman, R. C., and Damon, I. K. The Journal of Infectious Diseases. 2006; 194: 773–780.
7. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Hutin, Y. J., Williams, R. J., Malfait, P., Pebody, R., Loparev, V. N., Ropp, S. L., Rodriguez, M., Knight, J. C., Tshioko, F. K., Khan, A. S., Szczeniowski, M. V., and Esposito, J. J. Emerging Infectious Diseases. 2001; 7: 434–438.
8. Monkeypox virus detection in rodents using real-time 3'-minor groove binder TaqMan assays on the Roche LightCycler. Kulesh DA, Loveless BM, Norwood D, Garrison J, Whitehouse CA, Hartmann C, Mucker E, Miller D, Wasieloski LP Jr, Huggins J, Huhn G, Miser LL, Imig C, Martinez M, Larsen T, Rossi CA, Ludwig GV. Lab Invest. 2004; 84: 1200-1208.
9. A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. Parker S, Buller RM. Future Virol. 2013; 8: 129-157.
10. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Adler H, Gould S, Hine P, et al. The Lancet. Infectious diseases. 2022; 22: 1153–1162.
11. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus. Smith SK, Self J, Weiss S, et al. Journal of virology, 2011; 85: 9176–9187.
12. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. Lederman ER, Davidson W, Groff HL, et al. The Journal of Infectious Diseases. 2012; 206: 1372–1385.
13. Construction of Peptide Vaccine Candidate Based on β-Cell Epitopes of Indonesian Monkeypox Virus (MPXV) Virulence Protein: A Reverse Vaccinology. Viol Dhea Kharisma, A. N. M. Ansori, Ahmad Affan Ali Murtadlo, Muhammad Hermawan Widyananda, Emdad Ullah, Sin War Naw, Vikash Jakhmola, Kiran Dobhal, Tarun Parashar, Maksim Rebezov, Rahadian Zainul. Research Journal of Pharmacy and Technology. 2024; 17.
14. Stigma and Discrimination During COVID-19 Pandemic. Bhanot D, Singh T, Verma SK, Sharad S., Frontiers in Public Health. 2021; 8.
15. What is a resilient health system? Lessons from Ebola. Kruk ME, Myers M, Varpilah ST, Dahn BT. 9980. Lancet. 2015; 385: 1910–1912.
16. Community engagement for health system resilience: evidence from Liberia's Ebola epidemic. Barker KM, Ling EJ, Fallah M, et al. Health Policy Plan. 2020; 35: 416-423.
17. Smallpox: emergence, global spread, and eradication. F., Fenner. 3. History and Philosophy of the Life Sciences. 1993; 15: 397–420.
18. The One Health Concept: 10 Years Old and a Long Road Ahead. Destoumieux-Garzón D, Mavingui P, Boetsch G, et al. Frontiers in veterinary science. 2018; 5.
19. The Impact of Epidemics and Pandemics on the Mental Health of Healthcare Workers: A Systematic Review. Chigwedere OC, Sadath A, Kabir Z, Arensman E. International Journal of Environmental Research and Public Health. 2021; 18.